Viewing Study NCT05168618


Ignite Creation Date: 2025-12-25 @ 4:55 AM
Ignite Modification Date: 2026-01-15 @ 1:41 PM
Study NCT ID: NCT05168618
Status: RECRUITING
Last Update Posted: 2025-05-07
First Post: 2021-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Sponsor: University of Utah
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module